Overactive Bladder Treatment Global Market Report 2023

Overactive Bladder Treatment Global Market Report 2023 – By Diseases Type (Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity), By Therapy (Anticholinergics, Mirabegron, Neurostimulation, Intravesical Instillation, Other Therapies), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : July 2023 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Overactive Bladder Treatment Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN

Overactive bladder refers to a collection of symptoms that may affect how often a person pees and the urgency. Treatment includes changing certain behaviours and incorporating pelvic floor muscle exercises, and others to eliminate symptoms. Treatment can be helpful for relieving the symptoms of an overactive bladder and reducing episodes of urgent incontinence.

The main types of diseases in overactive bladder treatment are idiopathic bladder overactivity and neurogenic bladder overactivity. Idiopathic bladder overactivity refers to an involuntary contraction of the bladder muscle that causes a sudden and urgent need to urinate and is treated by overactive bladder (OAB) treatment therapies with anticholinergics and beta-3 agonists. The diseases are treated by various therapies including anticholinergics, mirabegron, neurostimulation, intravesical instillation, and other therapies distributed by channels such as hospital pharmacies, drug stores, retail pharmacies, and online providers.

The global overactive bladder treatment market is segmented -

1) By Diseases Type: Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity

2) By Therapy: Anticholinergics, Mirabegron, Neurostimulation, Intravesical Instillation, Other Therapies

3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

The global overactive bladder treatment market size is expected to grow from $2.90 billion in 2022 to $3.01 billion in 2023 at a compound annual growth rate (CAGR) of 3.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global overactive bladder treatment market size is expected to reach $3.51 billion in 2027 at a CAGR of 3.9%.

A rising geriatric population is expected to boost the growth of the overactive bladder treatment market going forward. The geriatric population refers to the population of people aged 65 and older. Geriatric patients are more vulnerable to urinary tract infections due to a variety of factors, such as decreased urine flow, an overactive bladder, an enlarged prostate, or kidney stones. This will propel demand for overactive bladder treatments. For instance, in February 2020, according to the United States Census Bureau, a US-based government agency responsible for collecting and publishing data about the population, economy, and geography, people aged 65 or older accounted for 56 million, or 17% of the total population in the USA. This population is expected to grow to 94 million by 2050, accounting for 23% of the total population. Therefore, the rising geriatric population is driving the growth of the overactive bladder treatment market.

Major players in the overactive bladder treatment market are AbbVie Inc., Astellas Pharma Inc., Laborie, Endo International Plc., Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson Services Inc., Medtronic Plc., Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Limited, Cogentix Medical Inc., Dr. Reddy’s Laboratories Ltd., Sumitomo Pharma Co. Ltd, Sun Pharmaceutical Industries Ltd., and Intas Pharmaceuticals Limited.

Technological advancements are a popular trend in the overactive bladder treatment market. Major companies operating in the market are introducing advanced products integrated with latest technologies to sustain their position in the market. For instance, in August 2020, Medtronic Plc, an Ireland-based medical technology company, launched the New InterStim Micro Neurostimulator for sacral neuromodulation (SNM) therapy. The InterStim Micro neurostimulator boasts the innovative SureScan MRI technology, allowing for complete MRI conditional scans of the entire body. Sacral neuromodulation utilizes electrical impulses to enhance bladder and bowel control by directly modulating nerve activity in the lower back. This method normalizes communication between the bladder and the brain, offering better control of symptoms.

In March 2021, Sumitovant Biopharma, a US-based biopharmaceutical company, acquired Urovant Sciences Ltd. for an undisclosed amount. This acquisition is expected to provide capital for long-term business objectives and ensure focus on Sumitovant’s mission to develop and commercialize innovative therapies for its patients. Urovant Sciences Ltd. is a Switzerland-based clinical-stage biopharmaceutical company that is focused on developing and commercializing innovative therapies for urologic conditions, including overactive bladder (OAB) treatments.

North America was the largest region in the overactive bladder treatment market in 2022. Asia-Pacific is expected to be the fastest-growing region in the global overactive bladder treatment market report during the forecast period. The regions covered in the global overactive bladder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the overactive bladder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The overactive bladder treatment market consists of revenues earned by entities by providing treatments such as behavioral therapies, nerve stimulation, and percutaneous tibial nerve stimulation (PTNS). The market value includes the value of related goods sold by the service provider or included within the service offering. The overactive bladder treatment market also includes sales of medications used in providing overactive bladder treatment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The overactive bladder treatment market research report is one of a series of new reports from The Business Research Company that provides overactive bladder treatment market statistics, including overactive bladder treatment industry global market size, regional shares, competitors with an overactive bladder treatment market share, detailed overactive bladder treatment market segments, market trends and opportunities, and any further data you may need to thrive in the overactive bladder treatment industry. This overactive bladder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Overactive Bladder Treatment Market Characteristics

    3. Overactive Bladder Treatment Market Trends And Strategies

    4. Overactive Bladder Treatment Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Overactive Bladder Treatment Market

    4.2. Ukraine-Russia War Impact On Overactive Bladder Treatment Market

    4.3. Impact Of High Inflation On Overactive Bladder Treatment Market

    5. Overactive Bladder Treatment Market Size And Growth

    5.1. Global Overactive Bladder Treatment Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Overactive Bladder Treatment Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Overactive Bladder Treatment Market Segmentation

    6.1. Global Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Idiopathic Bladder Overactivity

    Neurogenic Bladder Overactivity

    6.2. Global Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Anticholinergics

    Mirabegron

    Neurostimulation

    Intravesical Instillation

    Other Therapies

    6.3. Global Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospital Pharmacies

    Drug Stores And Retail Pharmacies

    Online Providers

    7. Overactive Bladder Treatment Market Regional And Country Analysis

    7.1. Global Overactive Bladder Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Overactive Bladder Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Overactive Bladder Treatment Market

    8.1. Asia-Pacific Overactive Bladder Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Overactive Bladder Treatment Market

    9.1. China Overactive Bladder Treatment Market Overview

    9.2. China Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Overactive Bladder Treatment Market

    10.1. India Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Overactive Bladder Treatment Market

    11.1. Japan Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Overactive Bladder Treatment Market

    12.1. Australia Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Overactive Bladder Treatment Market

    13.1. Indonesia Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Overactive Bladder Treatment Market

    14.1. South Korea Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Overactive Bladder Treatment Market

    15.1. Western Europe Overactive Bladder Treatment Market Overview

    15.2. Western Europe Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Overactive Bladder Treatment Market

    16.1. UK Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Overactive Bladder Treatment Market

    17.1. Germany Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Overactive Bladder Treatment Market

    18.4. France Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Overactive Bladder Treatment Market

    19.1. Eastern Europe Overactive Bladder Treatment Market Overview

    19.2. Eastern Europe Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Overactive Bladder Treatment Market

    20.1. Russia Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Overactive Bladder Treatment Market

    21.1. North America Overactive Bladder Treatment Market Overview

    21.2. North America Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Overactive Bladder Treatment Market

    22.1. USA Overactive Bladder Treatment Market Overview

    22.2. USA Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Overactive Bladder Treatment Market

    23.1. South America Overactive Bladder Treatment Market Overview

    23.2. South America Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Overactive Bladder Treatment Market

    24.1. Brazil Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Overactive Bladder Treatment Market

    25.1. Middle East Overactive Bladder Treatment Market Overview

    25.2. Middle East Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Overactive Bladder Treatment Market

    26.1. Africa Overactive Bladder Treatment Market Overview

    26.2. Africa Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Overactive Bladder Treatment Market Competitive Landscape And Company Profiles

    27.1. Overactive Bladder Treatment Market Competitive Landscape

    27.2. Overactive Bladder Treatment Market Company Profiles

    27.2.1. AbbVie Inc.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Astellas Pharma Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Laborie

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Endo International Plc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Hisamitsu Pharmaceutical Co. Inc.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Overactive Bladder Treatment Market

    29. Overactive Bladder Treatment Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Overactive Bladder Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Overactive Bladder Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: AbbVie Inc. Financial Performance
  • Table 47: Astellas Pharma Inc. Financial Performance
  • Table 48: Laborie Financial Performance
  • Table 49: Endo International Plc. Financial Performance
  • Table 50: Hisamitsu Pharmaceutical Co. Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Overactive Bladder Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Overactive Bladder Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: AbbVie Inc. Financial Performance
  • Figure 47: Astellas Pharma Inc. Financial Performance
  • Figure 48: Laborie Financial Performance
  • Figure 49: Endo International Plc. Financial Performance
  • Figure 50: Hisamitsu Pharmaceutical Co. Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report